Shanghai Serum Bio-Technology Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Serum Bio-Technology has a total shareholder equity of CN¥1.1B and total debt of CN¥758.4K, which brings its debt-to-equity ratio to 0.07%. Its total assets and total liabilities are CN¥1.1B and CN¥35.7M respectively. Shanghai Serum Bio-Technology's EBIT is CN¥38.3M making its interest coverage ratio -6.7. It has cash and short-term investments of CN¥846.4M.
Key information
0.07%
Debt to equity ratio
CN¥758.43k
Debt
Interest coverage ratio | -6.7x |
Cash | CN¥846.35m |
Equity | CN¥1.09b |
Total liabilities | CN¥35.65m |
Total assets | CN¥1.12b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688163's short term assets (CN¥940.4M) exceed its short term liabilities (CN¥17.8M).
Long Term Liabilities: 688163's short term assets (CN¥940.4M) exceed its long term liabilities (CN¥17.8M).
Debt to Equity History and Analysis
Debt Level: 688163 has more cash than its total debt.
Reducing Debt: 688163's debt to equity ratio has increased from 0% to 0.07% over the past 5 years.
Debt Coverage: 688163's debt is well covered by operating cash flow (3908.3%).
Interest Coverage: 688163 earns more interest than it pays, so coverage of interest payments is not a concern.